Literature DB >> 11722448

Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam.

J B van der Meer1, M L Schuttelaar, G G Toth, S H Kardaun, G Beerthuizen, M C de Jong, M F Jonkman, P Nieuwenhuis.   

Abstract

A 62-year-old female patient is described who developed toxic epidermal necrolysis (TEN) after medication with phenytoin and oxazepam. Initially phenytoin was discontinued and dexamethasone pulse therapy (1.5 mg/kg on 3 consecutive days) was initiated on the tenth day of skin disease. This resulted in clinical improvement. Histologically re-epithelialization could be demonstrated below the necrotic epidermis. However, on the eighteenth day of skin disease (10 days after discontinuation of phenytoin and 8 days after the start of dexamethasone pulse therapy), a histologically verified rebound-TEN developed with a detachment of 95%. Oxazepam was stopped and a second series of dexamethasone pulse therapy was given. Re-epithelialization began within 24 h of the start of the second series of dexamethasone pulse therapy, and continued to almost complete recovery within 1 week.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722448     DOI: 10.1046/j.1365-2230.2001.00910.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

2.  Toxic epidermal necrolysis associated with sorafenib and tosufloxacin in a patient with hepatocellular carcinoma.

Authors:  Mun Ki Choi; Hyun Young Woo; Jeong Heo; Mong Cho; Gwang Ha Kim; Geun Am Song; Moon Bum Kim
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

3.  Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone.

Authors:  Rusen Uzun; Arzu Didem Yalcin; Betul Celik; Tangul Bulut; Ata Nevzat Yalcin
Journal:  Am J Case Rep       Date:  2016-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.